 |
Imiglucerase |
|---|---|
| Trade Name | Cerezyme |
| Orphan Indication | Replacement therapy in patients with types I, II, and III Gaucher's disease |
| USA Market Approval | USA |
| USA Designation Date | 1991-11-05 00:00:00 |
| Sponsor | Genzyme Corporation;One Kendall Square;Cambridge, Massachusetts, 02139 |
